Core B- The Developmental (Dev) Core of the San Diego (SD) CFAR aims to support emerging investigators and promote innovative directions in HIV research. The Dev Core provides opportunities for junior investigators and investigators new to HIV research to generate preliminary data for larger grant applications through the awarding of pilot grants (up to $50K for 1 year). Developmental grants are also employed in the recruitment and retention of new HIV research faculty, who can in many cases apply for funding prior to their arrival. Applications are evaluated by the Developmental Grant Review Committee which represents a broad range of HIV research expertise and all four SD CFAR member institutions. In addition, two new categories of grant opportunities available to post-doctoral fellows (Next Generation Grants, up to $10K) and junior faculty with impending NIH R series grant applications (High Impact MicroGrants, up to $3K) are now offered to further leverage CFAR funding to assist these investigators in establishing productive HIV research careers. The Dev Core also collects data on the success of grant awardees in terms of resultant publications, additional grant funding, and career advancement. The Dev Core further cultivates the community of emerging HIV researchers through Training Workshops, seminars and formal mentorship opportunities. These include weekly Work-in-Progress, Journal Club and AIDS Clinical Rounds, mock NIH-style study section reviews for K and R series grant applications (OK Review), and a Leadership Academy where junior faculty are mentored and operate as CFAR Core co- directors. These programs facilitate the academic success of emerging researchers and prepare them for leadership roles. Finally, the Dev Core operates a Rapid Review Board for the efficient solicitation and review of applications for funding opportunities with quick turnaround times, such as certain foundation grants and Administrative Supplements. This Rapid Review Board identifies appropriate mentors for the applicants, provides constructive feedback, and in cases where there are limits on the number of applications, determines which applications are most likely to be successful. With the growth of the SD CFAR, the Dev Core can expand the number of innovative projects and training opportunities that it supports and more effectively cultivate the next generation of talented HIV investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-26
Application #
9906058
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
26
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :

Showing the most recent 10 out of 921 publications